Clinical trial
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
The intent of this study is to assess the safety of LY2409021 in participants with Type 2 diabetes mellitus taking metformin and sulfonylurea as prescribed by their personal physician. The study treatment is expected to last 12 months (52 weeks).
| Category | Value |
|---|---|
| Study start date | 2014-04-08 |